Extensive Subclinical Spread in In Situ Lentigo Maligna Melanoma

Defining Characteristics

The National Comprehensive Cancer Network recommends that subclinical extension, which represents the microscopic presence of tumor cells that cannot be detected by clinical examination alone, should be considered in the management of lentigo maligna melanoma 1, 2, 3
Atypical junctional melanocytic hyperplasia extends laterally beyond what is visible to the naked eye, making clinical margin determination unreliable, with extensions reaching several centimeters beyond the visible lesion borders 1, 4

The National Comprehensive Cancer Network suggests that standard 0.5 cm margins recommended for most melanoma in situ are frequently inadequate for lentigo maligna, and margins >0.5 cm are often necessary to achieve histologically negative margins in LM 1, 2, 4, 7
The American Academy of Dermatology notes that for large lesions or any LM on the head/neck, wider clinical margins are needed due to higher likelihood of subclinical spread 6, 7

The National Comprehensive Cancer Network recommends complete circumferential peripheral and deep margin assessment techniques, including Mohs micrographic surgery with permanent section analysis of the central debulking specimen, to improve histologic clearance and decrease local recurrence 2, 3, 5, 7, 8
Staged excision with formalin-fixed, paraffin-embedded sections is also recommended to address the subclinical spread 2, 3, 5

The British Journal of Dermatology and the American Academy of Dermatology report that local recurrence of lentigo maligna is common and typically represents persistent disease rather than true metastatic recurrence, attributed to the "field effect" and inadequate initial surgical margins 8, 9